The Journal of Neuroscience, April 15, 2003, 23(8):3364
Functional NMDA Receptor Subtype 2B Is Expressed in Astrocytes
after Ischemia In Vivo and Anoxia In
Vitro
Claudia
Krebs1, 2,
Herman B.
Fernandes1,
Claire
Sheldon1,
Lynn A.
Raymond1, 2, 3, and
Kenneth G.
Baimbridge1, 3
1 Department of Physiology, 2 Kinsmen
Laboratory, Department of Psychiatry, and 3 Brain Research
Centre, University of British Columbia, Vancouver, British Columbia V6T
1Z3, Canada
NMDA-type glutamate receptors play a critical role in neuronal
synaptogenesis, plasticity, and excitotoxic death. Recent studies indicate that functional NMDA receptors are also expressed in certain
glial populations in the normal brain. Using immunohistochemical methods, we detected the presence of the NMDA receptor 2B (NR2B) subunit of the NMDA receptor in neurons but not astrocytes in the CA1
and subicular regions of the rat hippocampus. However, after
ischemia-induced neuronal death in these regions, double immunohistochemical labeling revealed that NR2B subunits colocalized with the astrocyte marker glial fibrillary acid protein and with NR1
subunits that are required for functional NMDA receptors. NR2B
expression was first observed 3 d after ischemia and reached a
peak at 28 d. At 56 d, only a few NR2B-expressing astrocytes were still present. In vitro, when postnatal hippocampal
cultures were subjected to 5 min of anoxia, it resulted in NR2B
expression on astrocytes in the glial feed layer. Imaging of
intracellular calcium with postanoxic cultures and astrocytes isolated
acutely from the ischemic hippocampus revealed a rise in intracellular [Ca2+] after stimulation with the specific agonist
NMDA. The response could be blocked reversibly with the competitive
antagonist 2-amino-5-phosphonovalerate and attenuated by the
NR2B-selective antagonist ifenprodil. Control astrocytes were not
responsive to NMDA but responded to glutamate. An understanding of the
role of astrocytes that express functional NMDA receptors in response
to ischemia may guide development of novel stroke therapies.
Key words:
ischemia; anoxia; NMDA; astrocytes; NR2B; calcium
Copyright © 2003 Society for Neuroscience 0270-6474/03/2383364-09$05.00/0